Market Place
Reply
1. Paclitaxel (5 mg/ ml) Solution for Infusion. The required quantity is 300 units.
2. Rituximab (1x100 mg/ 10 ml and 1x 500 mg/ 50 ml) Concentrate Solution for Infusion. The required quantity is 6 units and 400 units respectively.
3. Trastuzumab (1x150 mg) Solution for Injection. The required quantity is 100 units.
4. Bevacizumab (25 mg/ ml) Concentrate Solution for Infusion. The required quantity is 5 units and 1,500 units.
5. Daratumumab (1x1800 mg/ 15 ml) Solution for injection. The required quantity is 1,000 units.
6. Apalutamide (112 x 60 mg) Tablets. The required quantity is 56,448 units.
7. Durvalumab (50 mg/ ml) Concentrate solution for infusion. The required quantity is 100 units and 960 units.
8. Siponimod (12 x 0.25 mg) Tablets. The required quantity is 600 units and 5,280 units.
9. Siponimod (28 x 2 mg) Tablets. The required quantity is 600 units and 14,168 units.
Comments :
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
info@indeximinternational.com
Indexim international, are one of the leading supplier, exporter and importer of Pharmaceutical formulation, Novel molecule, APIs, Vet.-APIs, reference standard,, Excipients, Intermediates, Solvents, Vitamins, Nutraceuticals and Dietary supplements. Regulatory documents service etc.
We are exporting several of our products to Latin American countries, Gulf & Asian countries and also a few products to Australia, UK & USA.
We are also contract manufacturer of APIs and attached is the list of products and by cooperation with other manufacturers in India . Also most of the products are from WHO cGMP , ISO , GMP manufacturers.
Indexim International
sales.indeximinternational@gmail.com
info@indeximinternational.com
GSTN-24AADFI5767R1ZO
IEC -CODE : 0811024407
jgq@yangzijiang.com
jgq@yangzijiang.com
I am Justin from Yangtze River Pharmaceutical Group in China
APIs and FDF can be manufactured by our company.
We can also CMO
If you need them, please contact me by Tel., WhatsApp and Wechat: +86 15261051195
Email: jgq@yangzijiang.com
director@systochem.com
Dear Sir,
Greetings of the day!!Namaste!!
We can surely supply the same. Please send us mail on director@systochem.com or whatsapp +91 9999653614.
www.systochem.com
Awaiting for your valuable response.
Thanks & Regards
hostrinlifesciences@gmail.com
Dear Friend,
Greetings from Hostrin Life sciences!!!
We have been supporting the following services.
1.We do support DMF for API, Tech transfer support and Registration of Dossiers in ROW/MOH /MHRA/EMEA/USA support in CTD, ACTD, eCTD and ANDA's formats with 5 modules including BA and BE studies /Clinical studies/trials for API's & Formulations in Pharmaceutical, Ayurveda, Biotech, Biosimilar, vitamins , Peptides and recently Transdermal patches too.
2. Impurity's & Reference standards support for API's
3. Services for IPR & Regulatory compliance
4. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.
5. Custom synthesis & Contract manufacturing services
6. Synthetic Resins technologies support
Pls don't hesitate to send your enquiry's. For your reference please go through our website www.hostringlobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343
param@alibababiotec.com
We can supply Oncology Drugs
param@alibababiotec.com
Interested
export@healthpharma.in
Dear Sir,
Greetings from Health Pharma...!!!
We can support you with your requirements. Kindly request you to send email for detailed information.
Looking forward to your positive response.
Thanks...!!!
